4//SEC Filing
Vu Quan Anh 4
Accession 0001437749-25-006297
CIK 0001645469other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:06 PM ET
Size
5.0 KB
Accession
0001437749-25-006297
Insider Transaction Report
Form 4
Vu Quan Anh
Chief Financial Officer
Transactions
- Award
Stock Options
2025-03-03+25,000→ 25,000 totalExercise: $30.93Exp: 2035-03-02→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]On March 3, 2025, the reporting person was granted 25,000 stock options, vesting 6/48ths (15,625 shares) on September 2, 2025, and 1/48th every month thereafter until the stock option is fully vested on March 3, 2029.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001892297
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:06 PM ET
- Size
- 5.0 KB